292 related articles for article (PubMed ID: 16406777)
1. Uropathogenic Escherichia coli as a model of host-parasite interaction.
Svanborg C; Bergsten G; Fischer H; Godaly G; Gustafsson M; Karpman D; Lundstedt AC; Ragnarsdottir B; Svensson M; Wullt B
Curr Opin Microbiol; 2006 Feb; 9(1):33-9. PubMed ID: 16406777
[TBL] [Abstract][Full Text] [Related]
2. TLR- and CXCR1-dependent innate immunity: insights into the genetics of urinary tract infections.
Ragnarsdóttir B; Fischer H; Godaly G; Grönberg-Hernandez J; Gustafsson M; Karpman D; Lundstedt AC; Lutay N; Rämisch S; Svensson ML; Wullt B; Yadav M; Svanborg C
Eur J Clin Invest; 2008 Oct; 38 Suppl 2():12-20. PubMed ID: 18826477
[TBL] [Abstract][Full Text] [Related]
3. Neutrophil recruitment, chemokine receptors, and resistance to mucosal infection.
Godaly G; Bergsten G; Hang L; Fischer H; Frendéus B; Lundstedt AC; Samuelsson M; Samuelsson P; Svanborg C
J Leukoc Biol; 2001 Jun; 69(6):899-906. PubMed ID: 11404374
[TBL] [Abstract][Full Text] [Related]
4. Pathogen-specific TLR signaling in mucosa: mutual contribution of microbial TLR agonists and virulence factors.
Sirard JC; Bayardo M; Didierlaurent A
Eur J Immunol; 2006 Feb; 36(2):260-3. PubMed ID: 16453385
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of pathogen-specific TLR4 activation in the mucosa: fimbriae, recognition receptors and adaptor protein selection.
Fischer H; Yamamoto M; Akira S; Beutler B; Svanborg C
Eur J Immunol; 2006 Feb; 36(2):267-77. PubMed ID: 16385628
[TBL] [Abstract][Full Text] [Related]
6. PapG-dependent adherence breaks mucosal inertia and triggers the innate host response.
Bergsten G; Samuelsson M; Wullt B; Leijonhufvud I; Fischer H; Svanborg C
J Infect Dis; 2004 May; 189(9):1734-42. PubMed ID: 15116313
[TBL] [Abstract][Full Text] [Related]
7. Impact of Toll-like receptor signalling on urinary tract infection.
Scherberich JE; Hartinger A
Int J Antimicrob Agents; 2008 Feb; 31 Suppl 1():S9-14. PubMed ID: 17942281
[TBL] [Abstract][Full Text] [Related]
8. A toll-like receptor that prevents infection by uropathogenic bacteria.
Zhang D; Zhang G; Hayden MS; Greenblatt MB; Bussey C; Flavell RA; Ghosh S
Science; 2004 Mar; 303(5663):1522-6. PubMed ID: 15001781
[TBL] [Abstract][Full Text] [Related]
9. Toll-like receptors recognize uropathogenic Escherichia coli and trigger inflammation in the urinary tract.
Anders HJ; Patole PS
Nephrol Dial Transplant; 2005 Aug; 20(8):1529-32. PubMed ID: 15941847
[No Abstract] [Full Text] [Related]
10. Intramacrophage survival of uropathogenic Escherichia coli: differences between diverse clinical isolates and between mouse and human macrophages.
Bokil NJ; Totsika M; Carey AJ; Stacey KJ; Hancock V; Saunders BM; Ravasi T; Ulett GC; Schembri MA; Sweet MJ
Immunobiology; 2011 Nov; 216(11):1164-71. PubMed ID: 21802164
[TBL] [Abstract][Full Text] [Related]
11. Enhancement of the innate immune response of bladder epithelial cells by Astragalus polysaccharides through upregulation of TLR4 expression.
Yin X; Chen L; Liu Y; Yang J; Ma C; Yao Z; Yang L; Wei L; Li M
Biochem Biophys Res Commun; 2010 Jun; 397(2):232-8. PubMed ID: 20546703
[TBL] [Abstract][Full Text] [Related]
12. The 'innate' host response protects and damages the infected urinary tract.
Svanborg C; Bergsten G; Fischer H; Frendéus B; Godaly G; Gustafsson E; Hang L; Hedlund M; Karpman D; Lundstedt AC; Samuelsson M; Samuelsson P; Svensson M; Wullt B
Ann Med; 2001 Dec; 33(9):563-70. PubMed ID: 11817650
[TBL] [Abstract][Full Text] [Related]
13. Modulation of host innate immune response in the bladder by uropathogenic Escherichia coli.
Billips BK; Forrestal SG; Rycyk MT; Johnson JR; Klumpp DJ; Schaeffer AJ
Infect Immun; 2007 Nov; 75(11):5353-60. PubMed ID: 17724068
[TBL] [Abstract][Full Text] [Related]
14. Current concepts of molecular defence mechanisms operative during urinary tract infection.
Weichhart T; Haidinger M; Hörl WH; Säemann MD
Eur J Clin Invest; 2008 Oct; 38 Suppl 2():29-38. PubMed ID: 18826479
[TBL] [Abstract][Full Text] [Related]
15. The humoral pattern recognition molecule PTX3 is a key component of innate immunity against urinary tract infection.
Jaillon S; Moalli F; Ragnarsdottir B; Bonavita E; Puthia M; Riva F; Barbati E; Nebuloni M; Cvetko Krajinovic L; Markotic A; Valentino S; Doni A; Tartari S; Graziani G; Montanelli A; Delneste Y; Svanborg C; Garlanda C; Mantovani A
Immunity; 2014 Apr; 40(4):621-32. PubMed ID: 24745336
[TBL] [Abstract][Full Text] [Related]
16. A role for collecting duct epithelial cells in renal antibacterial defences.
Chassin C; Tourneur E; Bens M; Vandewalle A
Cell Microbiol; 2011 Aug; 13(8):1107-13. PubMed ID: 21615666
[TBL] [Abstract][Full Text] [Related]
17. A live-attenuated vaccine for the treatment of urinary tract infection by uropathogenic Escherichia coli.
Billips BK; Yaggie RE; Cashy JP; Schaeffer AJ; Klumpp DJ
J Infect Dis; 2009 Jul; 200(2):263-72. PubMed ID: 19522648
[TBL] [Abstract][Full Text] [Related]
18. Interaction of uropathogenic Escherichia coli with host uroepithelium.
Kau AL; Hunstad DA; Hultgren SJ
Curr Opin Microbiol; 2005 Feb; 8(1):54-9. PubMed ID: 15694857
[TBL] [Abstract][Full Text] [Related]
19. Toll-like receptor 4 is needed to restrict the invasion of Escherichia coli P4 into mammary gland epithelial cells in a murine model of acute mastitis.
Gonen E; Vallon-Eberhard A; Elazar S; Harmelin A; Brenner O; Rosenshine I; Jung S; Shpigel NY
Cell Microbiol; 2007 Dec; 9(12):2826-38. PubMed ID: 17608742
[TBL] [Abstract][Full Text] [Related]
20. Flagellin/TLR5 signalling activates renal collecting duct cells and facilitates invasion and cellular translocation of uropathogenic Escherichia coli.
Bens M; Vimont S; Ben Mkaddem S; Chassin C; Goujon JM; Balloy V; Chignard M; Werts C; Vandewalle A
Cell Microbiol; 2014 Oct; 16(10):1503-17. PubMed ID: 24779433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
